{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:02:50Z","timestamp":1786446170326,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jval.2021.02.014","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T10:19:31Z","timestamp":1628245171000},"page":"1095-1101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Indirect Economic Burden of Sickle Cell Disease"],"prefix":"10.1016","volume":"24","author":[{"given":"David","family":"Holdford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Vendetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Sop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wally R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2021.02.014_bib1","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.jval.2021.02.014_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajh.21570","article-title":"The number of people with sickle-cell disease in the United States: national and state estimates","volume":"85","author":"Brousseau","year":"2010","journal-title":"Am J Hematol"},{"issue":"4 Suppl","key":"10.1016\/j.jval.2021.02.014_bib3","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"6","key":"10.1016\/j.jval.2021.02.014_bib5","first-page":"461","article-title":"Characteristics of pain managed at home in children and adolescents with sickle cell disease by using diary self-reports","volume":"3","author":"Dampier","year":"2002","journal-title":"J\u00a0Pain"},{"issue":"8","key":"10.1016\/j.jval.2021.02.014_bib6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00043426-200211000-00008","article-title":"Home management of pain in sickle cell disease: a daily diary study in children and adolescents","volume":"24","author":"Dampier","year":"2002","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"1-2","key":"10.1016\/j.jval.2021.02.014_bib7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.pain.2009.06.029","article-title":"Pain site frequency and location in sickle cell disease: the PiSCES project","volume":"145","author":"McClish","year":"2009","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.jval.2021.02.014_bib8","first-page":"490","article-title":"AAPT diagnostic criteria for chronic sickle cell disease pain","volume":"18","author":"Dampier","year":"2017","journal-title":"J\u00a0Pain"},{"issue":"1","key":"10.1016\/j.jval.2021.02.014_bib9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/asheducation-2017.1.435","article-title":"Chronic organ failure in adult sickle cell disease","volume":"2017","author":"Vichinsky","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"7","key":"10.1016\/j.jval.2021.02.014_bib10","first-page":"746","article-title":"AAAPT diagnostic criteria for acute sickle cell disease pain","volume":"20","author":"Field","year":"2019","journal-title":"J\u00a0Pain"},{"issue":"2","key":"10.1016\/j.jval.2021.02.014_bib11","first-page":"183","article-title":"Understanding pain and improving management of sickle cell disease: the PiSCES study","volume":"97","author":"Smith","year":"2005","journal-title":"J\u00a0Natl Med Assoc"},{"issue":"2","key":"10.1016\/j.jval.2021.02.014_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-148-2-200801150-00004","article-title":"Daily assessment of pain in adults with sickle cell disease","volume":"148","author":"Smith","year":"2008","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.jval.2021.02.014_bib13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.emc.2014.04.011","article-title":"Sickle cell disease in the emergency department","volume":"32","author":"Lovett","year":"2014","journal-title":"Emerg Med Clin North Am"},{"issue":"1","key":"10.1016\/j.jval.2021.02.014_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease. Rates and risk factors","volume":"325","author":"Platt","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.jval.2021.02.014_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ajh.21408","article-title":"The cost of health care for children and adults with sickle cell disease","volume":"84","author":"Kauf","year":"2009","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.jval.2021.02.014_bib16","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/pbc.23181","article-title":"High resource hospitalizations among children with vaso-occlusive crises in sickle cell disease","volume":"58","author":"Raphael","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.jval.2021.02.014_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001274","article-title":"Patient self-assessment of hospital pain, mood and health-related quality of life in adults with sickle cell disease","volume":"2","author":"Anie","year":"2012","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.jval.2021.02.014_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ajh.20336","article-title":"Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance","volume":"79","author":"Ballas","year":"2005","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.jval.2021.02.014_bib19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/pbc.22222","article-title":"Vaso-occlusive painful events in sickle cell disease: impact on child well-being","volume":"54","author":"Brandow","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.jval.2021.02.014_bib20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1586\/erp.09.32","article-title":"Pain management and quality of life in sickle cell disease","volume":"9","author":"Howard","year":"2009","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"6","key":"10.1016\/j.jval.2021.02.014_bib21","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jval.2015.05.009","article-title":"The iMTA Productivity Cost Questionnaire: a standardized instrument for measuring and valuing health-related productivity losses","volume":"18","author":"Bouwmans","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2021.02.014_bib23","series-title":"Methods for the Economic Evaluation of Healthcare Programmes","author":"Drummond","year":"2015"},{"issue":"2","key":"10.1016\/j.jval.2021.02.014_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00019053-200523020-00006","article-title":"Providing systematic guidance in pharmacoeconomic guidelines for analysing costs","volume":"23","author":"Jacobs","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2021.02.014_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.socscimed.2015.09.008","article-title":"Unpaid work in health economic evaluations","volume":"144","author":"Krol","year":"2015","journal-title":"Soc Sci Med"},{"issue":"1","key":"10.1016\/j.jval.2021.02.014_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1017\/S0266462300161100","article-title":"Measuring costs in cost-utility analyses. Variations in the literature","volume":"16","author":"Stone","year":"2000","journal-title":"Int J Technol Assess Health Care"},{"issue":"12","key":"10.1016\/j.jval.2021.02.014_bib27","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.jval.2018.04.1828","article-title":"Time is money: investigating the value of leisure time and unpaid work","volume":"21","author":"Verbooy","year":"2018","journal-title":"Value Health"},{"issue":"16","key":"10.1016\/j.jval.2021.02.014_bib28","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.jval.2021.02.014_bib30","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V122.21.2244.2244","article-title":"Occupational history for adults with sickle cell disease compared with healthy siblings","volume":"122","author":"Idowu","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jval.2021.02.014_bib31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1037\/0278-6133.23.3.267","article-title":"Daily mood and stress predict pain, health care use, and work activity in African American adults with sickle-cell disease","volume":"23","author":"Gil","year":"2004","journal-title":"Health Psychol"},{"issue":"4","key":"10.1016\/j.jval.2021.02.014_bib32","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1353\/hpu.2010.0945","article-title":"Predictors of employment status among African Americans with sickle cell disease","volume":"21","author":"Bediako","year":"2010","journal-title":"J\u00a0Health Care Poor Underserved"},{"issue":"11","key":"10.1016\/j.jval.2021.02.014_bib33","first-page":"993","article-title":"Multicenter Study of Hydroxyurea in Sickle Cell Anemia. The impact of hydroxyurea on career and employment of patients with sickle cell anemia","volume":"102","author":"Ballas","year":"2010","journal-title":"J\u00a0Natl Med Assoc"},{"issue":"2","key":"10.1016\/j.jval.2021.02.014_bib34","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1353\/hpu.2018.0060","article-title":"Social and behavioral factors in sickle cell disease: employment predicts decreased health care utilization","volume":"29","author":"Williams","year":"2018","journal-title":"J\u00a0Health Care Poor Underserved"},{"issue":"1-3","key":"10.1016\/j.jval.2021.02.014_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pain.2007.02.008","article-title":"The role of catastrophizing in sickle cell disease--the PiSCES project","volume":"133","author":"Citero","year":"2007","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.jval.2021.02.014_bib36","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.psym.2011.01.010","article-title":"Somatic symptom burden in adults with sickle cell disease predicts pain, depression, anxiety, health care utilization, and quality of life: the PiSCES project","volume":"52","author":"Sogutlu","year":"2011","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1016\/j.jval.2021.02.014_bib37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/PSY.0b013e31815ff5c5","article-title":"Depression and anxiety in adults with sickle cell disease: the PiSCES project","volume":"70","author":"Levenson","year":"2008","journal-title":"Psychosom Med"},{"issue":"8","key":"10.1016\/j.jval.2021.02.014_bib38","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/AJP.0b013e31814da3eb","article-title":"Fear of movement (kinesiophobia), pain, and psychopathology in patients with sickle cell disease","volume":"23","author":"Pells","year":"2007","journal-title":"Clin J Pain"},{"issue":"3","key":"10.1016\/j.jval.2021.02.014_bib39","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s10865-018-9918-7","article-title":"Temporal relationship between daily pain and actigraphy sleep patterns in pediatric sickle cell disease","volume":"41","author":"Fisher","year":"2018","journal-title":"J\u00a0Behav Med"},{"issue":"3","key":"10.1016\/j.jval.2021.02.014_bib40","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s11325-018-1630-x","article-title":"Comorbid obstructive sleep apnea and increased risk for sickle cell disease morbidity","volume":"22","author":"Katz","year":"2018","journal-title":"Sleep Breath"},{"issue":"2","key":"10.1016\/j.jval.2021.02.014_bib41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MPH.0000000000001067","article-title":"Sleep problem risk for adolescents with sickle cell disease: sociodemographic, physical, and disease-related correlates","volume":"40","author":"Valrie","year":"2018","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.jval.2021.02.014_bib42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.sleep.2016.05.006","article-title":"Sleep-disordered breathing and nocturnal hypoxemia in young adults with sickle cell disease","volume":"22","author":"Whitesell","year":"2016","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.jval.2021.02.014_bib43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pmn.2015.09.002","article-title":"Acute pain and depressive symptoms: independent predictors of insomnia symptoms among adults with sickle cell disease","volume":"17","author":"Moscou-Jackson","year":"2016","journal-title":"Pain Manag Nurs"},{"issue":"1","key":"10.1016\/j.jval.2021.02.014_bib44","first-page":"15","article-title":"Sleep quality, pain and self-efficacy among community-dwelling adults with sickle cell disease","volume":"26","author":"Adegbola","year":"2015","journal-title":"J\u00a0Natl Black Nurs Assoc"},{"issue":"1","key":"10.1016\/j.jval.2021.02.014_bib45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1043454213514632","article-title":"Fatigue in adolescents and young adults with sickle cell disease: biological and behavioral correlates and health-related quality of life","volume":"31","author":"Ameringer","year":"2014","journal-title":"J\u00a0Pediatr Oncol Nurs"},{"issue":"8","key":"10.1016\/j.jval.2021.02.014_bib46","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/MPH.0000000000000431","article-title":"Fatigue in children with sickle cell disease: association with neurocognitive and social-emotional functioning and quality of life","volume":"37","author":"Anderson","year":"2015","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.jval.2021.02.014_bib47","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1348\/135910702760213724","article-title":"The psychosocial experience of people with sickle cell disease and its impact on quality of life: qualitative findings from focus groups","volume":"7","author":"Thomas","year":"2002","journal-title":"Br J Health Psychol"},{"issue":"4","key":"10.1016\/j.jval.2021.02.014_bib48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40273-014-0132-3","article-title":"How to estimate productivity costs in economic evaluations","volume":"32","author":"Krol","year":"2014","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"10.1016\/j.jval.2021.02.014_bib49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.socscimed.2010.10.026","article-title":"Measuring and valuing productivity loss due to poor health: a critical review","volume":"72","author":"Zhang","year":"2011","journal-title":"Soc Sci Med"},{"issue":"5","key":"10.1016\/j.jval.2021.02.014_bib50","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2165\/00019053-200523050-00005","article-title":"Valuing patient and caregiver time: a review of the literature","volume":"23","author":"Tranmer","year":"2005","journal-title":"Pharmacoeconomics"},{"issue":"7","key":"10.1016\/j.jval.2021.02.014_bib51","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s40273-013-0056-3","article-title":"Productivity costs in economic evaluations: past, present, future","volume":"31","author":"Krol","year":"2013","journal-title":"Pharmacoeconomics"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109830152101490X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109830152101490X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:23:35Z","timestamp":1761096215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109830152101490X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S109830152101490X"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2021.02.014","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indirect Economic Burden of Sickle Cell Disease","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2021.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}